Invited commentary.
Dormond
Olivier
O
Bulfinch 119, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114, USA. olivier.dormand@tbrc.mgh.harvard.edu
Madsen
Joren C
JC
D000818:Animals; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000494:pharmacology* / Q000627:therapeutic use; D004730:Endothelium, Vascular / Q000166:cytology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D019650:Hematopoietic Stem Cell Mobilization; D017202:Myocardial Ischemia / Q000503:physiopathology*; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D051381:Rats; D011917:Rats, Inbred Lew; D033581:Stem Cell Transplantation; D017154:Stromal Cells
D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D016178:Granulocyte-Macrophage Colony-Stimulating Factor